More
    Guided Solutions - Connecting Talent With Innovation/div>

    Liberate Medical starts neuromuscular stimulator trial with $6.5m grant

    Liberate Medical has commenced patient enrolment in a study investigating its neuromuscular electrical stimulator to help respiratory failure patients wean off mechanical ventilation. The study,...

    enVVeno Medical’s VenoValve proves effective in study

    EnVVeno Medical announced positive topline efficacy data from its SAVVE clinical trial examining its VenoValve, demonstrating that 94% of patients using the valve showed...

    Hyperfine starts enrolment in portable imaging workflow study

    US-based health technology company Hyperfine has enrolled the first patient in the clinical workflow study of its US Food and Drug Administration (FDA)-approved portable...

    CVRx has more data supporting long-term benefits of Barostim

    CVRx announced the publication of post-market data highlighting long-term, sustained benefits with its Barostim device.Minneapolis-based CVRx published results from the BeAT-HF trial in the...

    QT imaging’s breast imaging system proves as effective as mammography

    Medical device company QT Imaging Holdings has announced positive data demonstrating that its Breast Acoustic CT scan imaging technique can be used as a...

    Sight Sciences touts eye pressure reduction with glaucoma OMNI device

    US-based Sight Sciences has published the two-year post-surgical outcomes of its minimally invasive glaucoma surgery device, the OMNI surgical system. The data from the real-world...

    Signati kicks off trial investigating quicker vasectomy device

    Signati Medical has enrolled the first patient in a clinical trial investigating its device designed to quicken vasectomy procedures. The trial, operating under an investigative...

    Photopharmics kickstarts phototherapy trial for Parkinson’s disease 

    US-based equipment manufacturer Photopharmics has announced the initiation of its ‘Celeste light for PD’ clinical trial investigating the Celeste phototherapy device.  The US Food and...

    Novocure’s TTFields device slows metastasis in NSCLC

    NovoCure’s Tumor Treating Fields (TTFields) therapy met its primary endpoint in the Phase III METIS trial by slowing the progression of brain metastasis in...

    Latest articles